Amplifon S.p.A Change in Accounts Receivable 2019-2025 | AMFPF

Amplifon S.p.A change in accounts receivable from 2019 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.

Amplifon S.p.A Change in Accounts Receivable 2019-2025 | AMFPF

Amplifon S.p.A change in accounts receivable from 2019 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$147.3B
CVS Health (CVS)$83.1B
Elevance Health (ELV)$65.9B
Cencora (COR)$56B
DiDi Global (DIDIY)$26.7B
Labcorp Holdings (LH)$22.4B
Natera (NTRA)$21.9B
BioMerieux (BMXMF)$17.2B
EUROFINS SCIENT (ERFSF)$15.3B
ICON (ICLR)$13.7B
CochLear (CHEOY)$13.3B
Medpace Holdings (MEDP)$12.9B
Solventum (SOLV)$12.5B
Viatris (VTRS)$11.8B
Revvity (RVTY)$10.2B
Sonic Healthcare (SKHHY)$9.2B
Avantor (AVTR)$8.6B
Caris Life Sciences,�Inc (CAI)$8.3B
HealthEquity (HQY)$8B
Charles River Laboratories (CRL)$7.5B
Bausch + Lomb (BLCO)$4.9B
Sotera Health (SHC)$4.2B
BrightSpring Health Services (BTSG)$3.8B
GeneDx Holdings (WGS)$3.3B
Surgery Partners (SGRY)$2.9B
Alignment Healthcare (ALHC)$2.9B
Concentras Parent (CON)$2.9B
Organon (OGN)$2.4B
Premier (PINC)$2B
Progyny (PGNY)$1.9B